We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Are Syrian refugee breast cancer patients diagnosed at advanced stage and do they have treatment delays?

    Ogur Karhan

    *Author for correspondence: Tel.: +90 414 318 6000;

    E-mail Address: dr_karhan@yahoo.com

    Mehmet Akif Inan Training & Research Hospital, Medical Oncology, Sanliurfa, 63040, Turkey

    ,
    Şaban Secmeler

    Mehmet Akif Inan Training & Research Hospital, Medical Oncology, Sanliurfa, 63040, Turkey

    ,
    Yasin Sezgin

    Siirt Training & Research Hospital, Medical Oncology, Siirt, 5600, Turkey

    ,
    Serdar Ileri

    Dicle University School of Medicine, Medical Oncology, Diyarbakır, 21280, Turkey

    &
    Halis Yerlikaya

    Diyarbakır Memorial Hospital, Medical Oncology, Diyarbakır, 21070, Turkey

    Published Online:https://doi.org/10.2217/fon-2022-1093

    Aim: To compare the clinicopathological features and time to reach treatment of patients with breast cancer among Syrian refugees (SR) and Turkish citizens (TC). Methods: Retrospective data from 2014 to 2021 were extracted from the hospital database. Student’s t-test, Mann–Whitney U test and χ2 test were used to compare the two groups. Results: Data of 88 SR and 402 TC patients were analyzed. The mean age was 45 years for SRs and 50 years for TCs. Breast cancer subtypes were similar in both groups. The de novo metastatic ratio was 23% in SRs and 21.3% in TCs and the time to reach treatment was similar between the two groups. Conclusion: Provided the absence of any obstacle in the healthcare system, SRs are diagnosed and treated like the citizens of their host nation.

    Tweetable abstract

    Patients with breast cancer among Syrian refugees are younger but are not diagnosed and treated later than Turkish citizens. #Syrian #refugees #TreatmentDelay #BreastCancer

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. UNHCR. Global trends: forced displacement in 2015. www.unhcr.org/576408cd7 (Accessed 2 February 2018).
    • 2. Doocy S, Lyles E, Akhu-Zaheya L et al. Health service utilization among Syrian refugees with chronic health conditions in Jordan. PLOS ONE 11, e0150088 (2016).
    • 3. Sayan M, Eren MF, Kilic SS et al. Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey. BMC Cancer 22, 532 (2022). • One-fifth (20%) of Syrian refugees living in Turkey were deemed noncompliant to radiotherapy.
    • 4. Turkish Directorate of Migration Management. Temporary protection. www.goc.gov.tr/gecici-koruma5638 (Accessed 2 February 2023).
    • 5. Refugees Association (Turkey). Number of Syrians in Turkey. https://multeciler.org.tr/turkiyedeki-suriyeli-sayisi (Accessed 23 January 2023).
    • 6. Prevention and control of noncommunicable diseases in refugees and migrants Technical guidance. World Health Organization, Regional Office for Europe (March 2019). https://apps.who.int/iris/bitstream/handle/10665/311461/9789289053990eng.pdf?sequence=1&isAllowed=y
    • 7. Ruby A, Knight A, Perel P, Blanchet K et al. The effectiveness of interventions for non-communicable diseases in humanitarian crises: a systematic review. PLOS ONE 10(9), e0138303 (2015).
    • 8. UNHCR: Global Annual Report-Public Health 2007. United Nations High Commissioner for Refugees, Geneva (2008).
    • 9. Donev D, Onèeva1 S, Gligorov I. Refugee crisis in Macedonia during the Kosovo conflict in 1999. Croat. Med. J. 43, 184–189 (2002).
    • 10. Doocy S, Lyles E, Roberton T et al. Prevalence and care-seeking for chronic diseases among Syrian refugees in Jordan. BMC Public Health 15, 1097 (2015).
    • 11. United Nations High Commissioner for Refugees. UNHCR 2020 Annual Public Health Global Review (2021). www.unhcr.org/en-us/publications/brochures/60dc89e24/2020-annual-public-health-global-review.html (Accessed 20 October 2021).
    • 12. Burnett A, Peel M. Health needs of asylum seekers and refugees. BMJ 322(7285), 544–547 (2001).
    • 13. Alawa J, Hamade O, Alayleh A, Fayad L, Khoshnood K. Cancer awareness and barriers to medical treatment among Syrian refugees and Lebanese citizens in Lebanon. J. Cancer Educ. 35(4), 709–717 (2020).
    • 14. Spiegel P, Khalifa A, Mateen FJ. Cancer in refugees in Jordan and Syria between 2009 and 2012: challenges and the way forward in humanitarian emergencies. Lancet Oncol. 15, e290–7 (2014).
    • 15. Sedef AK, Temi YB, Bahceci A, Sedef AM. Retrospective case series study on basic epidemiological characteristics of the cancer diagnosed Syrian refugees in south of Turkey. EJMI 5(4), 496–499 (2021).
    • 16. Kutluk T, Koç M, Öner İ et al. Cancer among syrian refugees living in Konya Province, Turkey. Confl. Health 16, 3 (2022). • Study showing that the most common type of cancer is breast cancer and that 40% of refugees were diagnosed at advanced stage.
    • 17. Khan SM, Gillani J, Nasreen S, Zai S. Cancer in north west Pakistan and Afghan refugees. J. Pak. Med. Assoc. 47, 122–24 (1997).
    • 18. Mateen FJ, Carone M, Al-Saedy H et al. Cancer diagnoses in Iraqi refugees. Acta Oncol. 51(7), 950–951 (2012).
    • 19. Abdel-Razeq H, Tamimi F, Abdel-Razeq N et al. Late presentation and suboptimal treatment of breast cancer among Syrian refugees: a retrospective study. J. Int. Med. Res. 49(5), 3000605211018448 (2021). •• Breast cancer Syrian refugees in Jordan were diagnosed at the advanced stage and were not properly treated.
    • 20. El Saghir NS, Soto Pérez de Celis E, Fares JE, Sullivan R. Cancer care for refugees and displaced populations: Middle East conflicts and global natural disasters. Am. Soc. Clin. Oncol. Educ. Book 38, 433–440 (2018). • Wars, conficts and natural disasters can cause major destruction and disruption for patients already getting treatment for cancer and delays in the diagnosis and treatment of displaced people.
    • 21. Göktaş B, Yılmaz S, Gönenç İM, Akbulut Y, Sözüer A. Cancer incidence among Syrian refugees in Turkey, 2012–2015. J. Int. Migr. Integr. 19(2), 253–258 (2018).
    • 22. Iqbal J, Ginsburg O, Fischer HD et al. A population-based cross-sectional study comparing breast cancer stage at diagnosis between immigrant and Canadian-born women in Ontario. Breast J. 23(5), 525–536 (2017). •• Immigrants were younger than Canada-born women and immigrant women were less likely to be diagnosed with stage I breast cancers than Canadian-born women.
    • 23. Mansour A, Al-Omari A, Sultan I. Burden of cancer among Syrian refugees in Jordan. J. Glob. Oncol. 4, 1–6 (2018).
    • 24. Cardoso F, Kyriakides S, Ohno S, ESMO Guidelines Committee. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann. Oncol. 30(8), 1194–1220 (2019).
    • 25. Lohrisch C, Paltiel C, Gelmon K et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J. Clin. Oncol. 24(30), 4888–94 (2006)
    • 26. Al Qadire M, Aljezawi M, Al-Shdayfat N. Cancer awareness and barriers to seeking medical help among Syrian refugees in Jordan: a baseline study. J. Cancer Educ. 34, 19–25 (2019). •• The most common medical barrier for seeking medical help was the absence of medical insurance.
    • 27. Spiegel P, Khalifa A, Mateen F. Cancer in refugees in Jordan and Syria between 2009 and 2012: challenges and the way forward in humanitarian emergencies. Lancet Oncol. 15(7), e290–e297 (2014).
    • 28. Alawa J, Alhalabi F, Khoshnood K. Breast cancer management among refugees and forcibly displaced populations: a call to action. Curr. Breast Cancer Rep. 11, 129–135 (2019).
    • 29. Cavalli J. A perilous time for refugees with cancer. ASCO Post (25 May 2016). https://ascopost.com/issues/may-25-2016/a-perilous-time-for-refugees-with-cancer/
    • 30. Cousins S. Syrian crisis: health experts say more can be done. Lancet 385(9972), 931–934 (2015).
    • 31. Ozcurumez S. Lessons from Turkey: Syrians under temporary protection, health services and NGOs: Saime Ozcurumez. Eur. J. Pub. Health. 27(Suppl. 3), 105–122 (2017).